The release of quarterly earnings is a significant event for any company, as it provides a snapshot of financial health and performance. For Amicus Therapeutics, comparing these results with Wall Street estimates and previous year figures will help investors gauge the company's progress and market position. However, without specific details on whether the earnings met, exceeded, or fell short of expectations, the immediate impact on stock price is neutral.